Free Trial

Mangoceuticals (MGRX) SEC Filings & 10K Form

Mangoceuticals logo
$4.33 -0.39 (-8.26%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.39 +0.06 (+1.39%)
As of 02/21/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mangoceuticals SEC Filings

DateFilerForm TypeView
02/18/2025
8:00 AM
Mangoceuticals (Filer)
Form DEF 14A
02/12/2025
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
4:25 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:46 PM
Mangoceuticals (Filer)
Form PRE 14A
01/31/2025
4:25 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
4:28 PM
GREENFIELD INVESTMENTS LTD. (Filed by)
Mangoceuticals (Subject)
Form SCHEDULE 13G
01/21/2025
3:30 PM
Isaac Antonios (Reporting)
Mangoceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/21/2025
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
4:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
4:15 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
4:04 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
4:06 PM
JOHNSTON EUGENE M (Reporting)
Mangoceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
4:00 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
4:10 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:15 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
7:30 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
4:25 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
6:30 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
11:15 PM
Mangoceuticals (Filer)
Form EFFECT
08/30/2024
4:25 PM
Mangoceuticals (Filer)
Form AW
08/27/2024
6:45 PM
Cohen Jacob D. (Filed by)
Mangoceuticals (Subject)
Form SC 13D/A
08/27/2024
6:41 PM
Cohen Jacob D. (Reporting)
Mangoceuticals (Issuer)
Tiger Cub Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:41 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
8:25 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:15 PM
Mangoceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
7:00 AM
Mangoceuticals (Filer)
Form POS AM
07/11/2024
7:15 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:40 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
5:25 PM
Hamilton Alex P. (Reporting)
Mangoceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
9:20 AM
Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
Form 144/A
06/20/2024
5:11 PM
Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
Form 144/A
06/18/2024
1:57 PM
Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
12:28 PM
Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
4:15 PM
D'Alessio Lorraine Pamela (Reporting)
Mangoceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:15 PM
Cohen Jacob D. (Filed by)
Mangoceuticals (Subject)
Form SC 13D/A
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

06/05/2024
4:15 PM
Cohen Jacob D. (Reporting)
Mangoceuticals (Issuer)
Tiger Cub Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:15 PM
Mangoceuticals (Issuer)
MYERS KENNY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:15 PM
Hamilton Alex P. (Reporting)
Mangoceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:15 PM
Hammer Amanda Elizabeth (Reporting)
Mangoceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:15 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
12:59 PM
Mangoceuticals (Filer)
Form ARS
05/16/2024
8:19 AM
Mangoceuticals (Filer)
Form DEF 14A
05/15/2024
3:52 PM
Mangoceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
8:00 AM
Mangoceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2024
11:15 PM
Mangoceuticals (Filer)
Form EFFECT
05/06/2024
4:32 PM
Mangoceuticals (Filer)
Form S-1/A
05/06/2024
3:43 PM
Mangoceuticals (Filer)
Form PRE 14A
05/02/2024
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
7:30 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
4:28 PM
Mangoceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/11/2024
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
4:21 PM
Mangoceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
4:28 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
8:00 AM
Mangoceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MGRX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners